Updated:
STERIS Corporation
STERIS Corporation provides infection prevention products and sterilization services to hospitals, surgery centers, and life science manufacturers...
STERIS Corporation
Founded in Ohio in 1985 as Innovative Medical Technologies, STERIS was renamed in 1987 and has since grown through acquisitions — incorporating businesses like American Sterilizer Company with much longer operating histories. The company's mission is to help customers create a healthier and safer world through infection prevention and procedural support. Its operational headquarters is in Mentor, Ohio. STERIS sells consumable products (detergents, endoscopy accessories, barrier products, instruments), services (equipment installation and maintenance, microbial reduction, instrument repair, laboratory testing, outsourced reprocessing), and capital equipment (sterilizers, surgical tables, automated endoscope reprocessors, operating room integration). The company targets hospitals, surgery centers, and medical device, pharmaceutical, and biotechnology manufacturers. It operates across North America, Europe, Latin America, and Asia-Pacific, with customer service centers in Mentor, Ohio, and global sterilization and laboratory locations. STERIS does not disclose total revenue or employee headcount on its public-facing site. The company operates as a publicly traded entity (NYSE: STE) with investor relations covering press releases, stock information, financials, and corporate governance. No additional offices or adjacent vehicles are named in available sources. The most recent verifiable activity is ongoing: as of 2026, the company continues to provide its core products and services globally, with its latest investor relations materials posted on its site. (No specific date for a recent event is available from public sources.) STERIS is structured as a public company, not a family office or private investment vehicle. Its primary structural differentiator is its breadth — offering a single-source portfolio of equipment, consumables, and services covering the full sterilization lifecycle. This integrated model is unusual among infection prevention companies and creates recurring revenue through consumables and service contracts attached to installed capital equipment. The separation between the operating business and any family-office investment arm is not disclosed; no philanthropic foundation or separate investment vehicle is mentioned on the company website.
General information
Firm type
Corporation
Year founded
1985
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Mentor
Corporate office
Mentor, OH, United States
Sector focus
Frequently asked questions
Who runs investment decisions at STERIS?
STERIS is a publicly traded company with a board of directors and executive leadership. The CEO and CFO lead capital allocation decisions, including acquisitions and internal investments. Specific principals are not named in the available public sources, though investor relations materials list contact information for shareholder inquiries.
Is STERIS structured as a family office or a public company?
STERIS is a public company listed on the NYSE (ticker: STE), not a family office. It does not operate a disclosed single-family office or multi-family office structure alongside the operating business. Its capital allocation is driven by public shareholder returns, not private family wealth.
How does STERIS source products and innovations?
STERIS develops internal products and also acquires companies with established product lines and operating histories. Its website cites historical acquisitions, including American Sterilizer Company, which augment its sterilization and surgical equipment offerings. The company does not disclose a separate venture arm or proprietary deal-flow network.
What investment stages does STERIS typically target?
STERIS does not target investment stages as a venture firm or private equity fund. It operates as a manufacturer and service provider of infection prevention products. Its acquisitions have historically focused on mature businesses with complementary product lines or service capabilities. No direct early-stage or growth-equity investments are disclosed.
Which sectors does STERIS serve?
STERIS serves the healthcare sector, specifically hospitals and surgery centers (infection prevention, sterilization, endoscopy, surgical tools) and the life science industry (biotechnology, pharmaceutical, and medical device manufacturers). It also serves research laboratories. The company explicitly avoids consumer-facing wellness products and unrelated industrial verticals, focusing on regulated medical and scientific environments.
How is STERIS related to the broader Altss entity ecosystem?
STERIS is a publicly traded operating company, not a family office or investment vehicle. It appears in Altss records as a portfolio entity due to its role as a medical-technology provider that may be held by family offices or endowments as an investment. No ownership or control by a family office is disclosed on the company website.
Where does the underlying wealth or capital for STERIS come from?
STERIS raises capital through public equity markets and debt issuance, not from a single family or individual. Its investor relations page lists financials, stock information, and dividend history, indicating capital comes from institutional and retail shareholders. No family-office capital source is disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: